Log In
BCIQ
Print this Print this
 

MP-110

  Manage Alerts
Collapse Summary General Information
Company Marathon Pharmaceuticals LLC
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard Indication Cancer (unspecified)
Indication DetailsTreat adrenal cortical carcinoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today